259 related articles for article (PubMed ID: 16756418)
1. A comparison between low-magnitude voucher and buprenorphine medication contingencies in promoting abstinence from opioids and cocaine.
Gross A; Marsch LA; Badger GJ; Bickel WK
Exp Clin Psychopharmacol; 2006 May; 14(2):148-56. PubMed ID: 16756418
[TBL] [Abstract][Full Text] [Related]
2. Effects of varying the monetary value of voucher-based incentives on abstinence achieved during and following treatment among cocaine-dependent outpatients.
Higgins ST; Heil SH; Dantona R; Donham R; Matthews M; Badger GJ
Addiction; 2007 Feb; 102(2):271-81. PubMed ID: 17222282
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of dose and contingency management procedures in LAAM-maintained cocaine-dependent patients.
Oliveto A; Poling J; Sevarino KA; Gonsai KR; McCance-Katz EF; Stine SM; Kosten TR
Drug Alcohol Depend; 2005 Aug; 79(2):157-65. PubMed ID: 16002025
[TBL] [Abstract][Full Text] [Related]
4. Buprenorphine medication versus voucher contingencies in promoting abstinence from opioids and cocaine.
Chopra MP; Landes RD; Gatchalian KM; Jackson LC; Buchhalter AR; Stitzer ML; Marsch LA; Bickel WK
Exp Clin Psychopharmacol; 2009 Aug; 17(4):226-36. PubMed ID: 19653788
[TBL] [Abstract][Full Text] [Related]
5. Behavioral drug and HIV risk reduction counseling (BDRC) with abstinence-contingent take-home buprenorphine: a pilot randomized clinical trial.
Chawarski MC; Mazlan M; Schottenfeld RS
Drug Alcohol Depend; 2008 Apr; 94(1-3):281-4. PubMed ID: 18164145
[TBL] [Abstract][Full Text] [Related]
6. Effects of voucher-based intervention on abstinence and retention in an outpatient treatment for cocaine addiction: a randomized controlled trial.
Garcia-Rodriguez O; Secades-Villa R; Higgins ST; Fernandez-Hermida JR; Carballo JL; Errasti Perez JM; Al-halabi Diaz S
Exp Clin Psychopharmacol; 2009 Jun; 17(3):131-8. PubMed ID: 19586227
[TBL] [Abstract][Full Text] [Related]
7. Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial.
Marsch LA; Bickel WK; Badger GJ; Stothart ME; Quesnel KJ; Stanger C; Brooklyn J
Arch Gen Psychiatry; 2005 Oct; 62(10):1157-64. PubMed ID: 16203961
[TBL] [Abstract][Full Text] [Related]
8. Buprenorphine treatment for opioid dependence: the relative efficacy of daily, twice and thrice weekly dosing.
Marsch LA; Bickel WK; Badger GJ; Jacobs EA
Drug Alcohol Depend; 2005 Feb; 77(2):195-204. PubMed ID: 15664721
[TBL] [Abstract][Full Text] [Related]
9. Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence.
Schottenfeld RS; Chawarski MC; Pakes JR; Pantalon MV; Carroll KM; Kosten TR
Am J Psychiatry; 2005 Feb; 162(2):340-9. PubMed ID: 15677600
[TBL] [Abstract][Full Text] [Related]
10. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study.
Peirce JM; Petry NM; Stitzer ML; Blaine J; Kellogg S; Satterfield F; Schwartz M; Krasnansky J; Pencer E; Silva-Vazquez L; Kirby KC; Royer-Malvestuto C; Roll JM; Cohen A; Copersino ML; Kolodner K; Li R
Arch Gen Psychiatry; 2006 Feb; 63(2):201-8. PubMed ID: 16461864
[TBL] [Abstract][Full Text] [Related]
11. Abstinence incentive effects in a short-term outpatient detoxification program.
Katz EC; Chutuape MA; Jones H; Jasinski D; Fingerhood M; Stitzer M
Exp Clin Psychopharmacol; 2004 Nov; 12(4):262-8. PubMed ID: 15571443
[TBL] [Abstract][Full Text] [Related]
12. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study.
Petry NM; Peirce JM; Stitzer ML; Blaine J; Roll JM; Cohen A; Obert J; Killeen T; Saladin ME; Cowell M; Kirby KC; Sterling R; Royer-Malvestuto C; Hamilton J; Booth RE; Macdonald M; Liebert M; Rader L; Burns R; DiMaria J; Copersino M; Stabile PQ; Kolodner K; Li R
Arch Gen Psychiatry; 2005 Oct; 62(10):1148-56. PubMed ID: 16203960
[TBL] [Abstract][Full Text] [Related]
13. Voucher-based contingent reinforcement of marijuana abstinence among individuals with serious mental illness.
Sigmon SC; Higgins ST
J Subst Abuse Treat; 2006 Jun; 30(4):291-5. PubMed ID: 16716843
[TBL] [Abstract][Full Text] [Related]
14. A randomized trial of long-term reinforcement of cocaine abstinence in methadone-maintained patients who inject drugs.
Silverman K; Robles E; Mudric T; Bigelow GE; Stitzer ML
J Consult Clin Psychol; 2004 Oct; 72(5):839-54. PubMed ID: 15482042
[TBL] [Abstract][Full Text] [Related]
15. The effectiveness of telephone-based continuing care for alcohol and cocaine dependence: 24-month outcomes.
McKay JR; Lynch KG; Shepard DS; Pettinati HM
Arch Gen Psychiatry; 2005 Feb; 62(2):199-207. PubMed ID: 15699297
[TBL] [Abstract][Full Text] [Related]
16. Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population.
Poling J; Oliveto A; Petry N; Sofuoglu M; Gonsai K; Gonzalez G; Martell B; Kosten TR
Arch Gen Psychiatry; 2006 Feb; 63(2):219-28. PubMed ID: 16461866
[TBL] [Abstract][Full Text] [Related]
17. Cocaine abstinence during methadone maintenance: effects of repeated brief exposure to voucher-based reinforcement.
Sigmon SC; Correia CJ; Stitzer ML
Exp Clin Psychopharmacol; 2004 Nov; 12(4):269-75. PubMed ID: 15571444
[TBL] [Abstract][Full Text] [Related]
18. Effects of methadone or buprenorphine maintenance on the subjective and reinforcing effects of intravenous cocaine in humans.
Foltin RW; Fischman MW
J Pharmacol Exp Ther; 1996 Sep; 278(3):1153-64. PubMed ID: 8819498
[TBL] [Abstract][Full Text] [Related]
19. Buprenorphine transdermal delivery system in adults with persistent noncancer-related pain syndromes who require opioid therapy: a multicenter, 5-week run-in and randomized, double-blind maintenance-of-analgesia study.
Landau CJ; Carr WD; Razzetti AJ; Sessler NE; Munera C; Ripa SR
Clin Ther; 2007 Oct; 29(10):2179-93. PubMed ID: 18042474
[TBL] [Abstract][Full Text] [Related]
20. A comparison of four buprenorphine dosing regimens in the treatment of opioid dependence.
Petry NM; Bickel WK; Badger GJ
Clin Pharmacol Ther; 1999 Sep; 66(3):306-14. PubMed ID: 10511067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
